A question about scientific publishing

I don’t really pay enough attention to know whether this is a new thing and I should just be used to it or not but I just received a strange editorial decision from an ACS journal (J. Med. Chem.).  The reviewers recommendations were:

1 – publish after major revisions [direct cost to author = $0]

2 – publish in JCIM [direct cost to author = $0]

3 – publish after major revisions [direct cost to author = $0]

 

Hardly a ringing endorsement of the paper but the editor’s decision is a bit troubling and I have to admit I didn’t even know it was something the ACS did.

Editors decision – transfer to ACS Omega [direct cost to author = $2000]

Is this just a feature of publishing that I need to get used to?  Are ACS editors in anyway incentivised (even indirectly via internal promotion of these pay-to-publish journals) to transfer papers in this direction?

This feels like two very different models of what scientific publishing is for shoe-horned into one organisation.  And on this occasion its an organisation carrying the name of a learned society which I think ought to favour one of those business models over the other.

I would be interested to know if this is a common experience which I should just get used to or if this something to be worried about?  Am I missing something?

 

Advertisements
A question about scientific publishing

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s